Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 5399-5405, September 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strobl, J. S.
Right arrow Articles by Worley, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strobl, J. S.
Right arrow Articles by Worley, J. F., III

Inhibition of Human Breast Cancer Cell Proliferation in Tissue Culture by the Neuroleptic Agents Pimozide and Thioridazine1

Jeannine S. Strobl2, Keith L. Kirkwood, Tracy K. Lantz, Michael A. Lewine, Virginia A. Peterson and Jennings F. Worley, III

Department of Pharmacology and Toxicology, West Virginia University Health Sciences Center, Morgantown, West Virginia 26506

Permanent cell culture lines derived from human breast cancer tissue are important experimental models in the study of human breast cancer cell proliferation. In the present work, pimozide, thioridazine, W-13, and W-12 were shown to inhibit MCF-7 human breast cancer cell growth. The 50% inhibition concentration values determined in two proliferation assays, [3H]thymidine incorporation and cell number, were in close agreement for each compound tested. The order of potency for growth inhibition in the presence of 2% stripped calf serum was pimozide (K1 2 µM) > thioridazine (K1 5 µM) > W-13 (K1 15 µM) > W-12 (K1 39 µM). Similar concentrations of these compounds blocked estradiol-induced growth of MCF-7 cells, but estrogen receptor (ER) interactions do not seem to be involved. Pimozide and thioridazine had no effect on the estradiol binding properties of the MCF-7 ER, nor did pimozide interfere with the induction of progesterone receptors by estradiol. Furthermore, pimozide also inhibited incorporation of [3H]thymidine into MCF-7 cells stimulated by polypeptide hormones in serum-free medium. The K1 for pimozide in serum-free medium alone, 0.46 µM, was similar to that determined in the presence of insulin (0.42 µM), insulin-like growth factor I (0.54 µM), and epidermal growth factor (0.43 µM). The effects of pimozide on breast cancer cell growth were not limited to the MCF-7 cell line. Pimozide also blocked cell growth and [3H]thymidine incorporation into the ER-positive T47D and ZR75-1B human breast cancer cell lines and the ER-negative human breast cancer cell line, MDA-MB-231. Although numerous mechanisms of action of pimozide and thioridazine have been identified, both drugs are calmodulin antagonists at drug concentrations that inhibit breast cancer cell growth in vitro. Inhibition of MCF-7 cell growth by the selective calmodulin antagonists W-13 and W-12 is consistent with a role for calmodulin antagonism in the broad growth-inhibitory properties of pimozide. We conclude that pimozide and thioridazine may be useful in the control of estradiol- and polypeptide hormone-induced growth of ER-positive and ER-negative human breast tumors.

1 Supported by Pharmaceutical Manufacturer's Association Research Starter Awards to J. S. S. and J. F. W., The Charleston Area Medical Center Foundation, and NIH Grants 3R25CA19530, DK33631, and CA46350.

2 To whom requests for reprints should be addressed, at Department of Pharmacology & Toxicology, West Virginia University, Morgantown, WV 26506.

Received 2/23/90. Revised 5/21/90.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Tuynder, G. Fiucci, S. Prieur, A. Lespagnol, A. Geant, S. Beaucourt, D. Duflaut, S. Besse, L. Susini, J. Cavarelli, et al.
Translationally controlled tumor protein is a target of tumor reversion
PNAS, October 26, 2004; 101(43): 15364 - 15369.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. E. Bertolesi, C. Shi, L. Elbaum, C. Jollimore, G. Rozenberg, S. Barnes, and M. E. M. Kelly
The Ca2+ Channel Antagonists Mibefradil and Pimozide Inhibit Cell Growth via Different Cytotoxic Mechanisms
Mol. Pharmacol., August 1, 2002; 62(2): 210 - 219.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. Hirooka, G. E. Bertolesi, M. E. M. Kelly, E. M. Denovan-Wright, X. Sun, J. Hamid, G. W. Zamponi, A. E. Juhasz, L. W. Haynes, and S. Barnes
T-Type Calcium Channel alpha 1G and alpha 1H Subunits in Human Retinoblastoma Cells and Their Loss After Differentiation
J Neurophysiol, July 1, 2002; 88(1): 196 - 205.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
A.A. Pantazaki and Th.S. Lialiaris
A combined biochemical and cytogenetic study of thioridazine-induced damage to nucleic acids
Mutagenesis, March 1, 1999; 14(2): 243 - 248.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. L. Kirkwood, K. Homick, M. B. Dragon, and P. G. Bradford
Cloning and Characterization of the Type I Inositol 1,4,5-Trisphosphate Receptor Gene Promoter. REGULATION BY 17beta -ESTRADIOL IN OSTEOBLASTS
J. Biol. Chem., September 5, 1997; 272(36): 22425 - 22431.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.